The stark divergence between SpaceX's targeted $1.75 trillion IPO valuation and Morningstar's estimate of $780 billion underscores fundamental tensions in how private technology companies are priced in an era of narrative-driven investing. According to Reuters, SpaceX is fixing its IPO price at $135 per share in an all-primary offering designed to raise a record $75 billion, with shares expected to begin trading on Nasdaq under ticker SPCX as soon as June 12. This structure directs proceeds to the company itself rather than early shareholders, while Elon Musk faces a 366-day lock-up period.

At the targeted valuation and with projected 2025 revenue around $18.7 billion primarily from Starlink, the implied multiple exceeds 90x sales despite recent net losses of nearly $5 billion. Morningstar equity analyst Nicolas Owens countered that the fair value sits closer to $780 billion, describing the company as 'significantly overvalued' with better entry points likely after the IPO. The firm notably downplayed xAI's Grok as a leading AI laboratory, challenging the narrative that bundles SpaceX's space ambitions with broader Musk ecosystem AI hype.

This gap reveals deeper issues few mainstream reports connect: the artificial inflation of private valuations through secondary share sales and tender offers that largely escaped rigorous public scrutiny. For years, SpaceX benefited from a closed ecosystem of venture capital, mutual funds, and sovereign investors chasing exposure to 'the next big thing' in reusable rockets, global broadband, and interplanetary expansion. These valuations were often set in information vacuums, detached from traditional metrics like consistent profitability or scalable unit economics beyond the Starlink moat.

The disconnect mirrors broader market froth visible in concentrated tech gains and speculative instruments like Polymarket bets currently giving nearly 90% odds of a post-IPO market cap above $1.8 trillion. It also foreshadows tests for other AI-centric unicorns such as OpenAI and Anthropic reportedly eyeing public debuts in SpaceX's wake. When private multiples meet public accountability, the results can recalibrate entire sectors. Morningstar's analysis highlights execution risks in satellite constellation scaling, regulatory hurdles for low-Earth orbit infrastructure, development costs for Starship, and the reality that space infrastructure remains capital intensive with long payback periods.

This moment transcends one company's pricing. It questions the sustainability of a financial system where story and scarcity (Musk's singular role across Tesla, xAI, Neuralink, and SpaceX) have substituted for fundamentals. As this record IPO proceeds, it may serve as a stress test for whether the post-pandemic era of easy capital and narrative premium can survive public market judgment. The roadshow beginning this week will reveal if institutional investors still reward the vision at 94x sales or if Morningstar's halving represents an early warning of mean reversion in tech valuations.